๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cancer of Head and Neck

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites๐Ÿ“ Guangdong๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site๐Ÿ“ Zhuhai Ming-Yuan Chen ยท Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participantsโ€ฆ Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Toripalimab, Carboplatin, Paclitaxel Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue NCT02584270NA1 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: Palatal Augmentation Prosthesis (PAP), Articulation Therapy Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis NCT07491536NA1 site๐Ÿ“ Pavia University of Pavia ยท Tests: Gas Ozone Therapy, Biomimetic Oral Care Regimen Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site๐Ÿ“ Boston Lumicell, Inc. ยท Tests: LUM015, LUM 2.6 Imaging Device To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies NCT07795034Phase 21 site๐Ÿ“ Xiamen Neuboron Bio-SciTech Co., Ltd. ยท Tests: Boron Neutron Capture Therapy Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07190755NA2 sites๐Ÿ“ Rouen๐Ÿ“ Vandล“uvre-lรจs-Nancy Centre Henri Becquerel ยท Tests: Remote symptoms moniotring Predicting Toxicity in Elderly Patients With Head and Neck Cancer NCT06344208n/a1 site๐Ÿ“ Milan European Institute of Oncology Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites๐Ÿ“ Atlanta๐Ÿ“ Chicago๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions NCT07532538n/a1 site๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma NCT05587543EARLY Phase 11 site๐Ÿ“ Shanghai Fudan University ยท Tests: PK Blood Collection, CAR, TCR An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847NA4 sites๐Ÿ“ Aurillac๐Ÿ“ Clermont-Ferrand๐Ÿ“ Lyon Centre Jean Perrin ยท Tests: blood sampling Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma NCT07125755Phase 37 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guilin Sun Yat-sen University ยท Tests: Cisplatin Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy NCT07104214n/a3 sites๐Ÿ“ Hangzhou๐Ÿ“ Jiaxing๐Ÿ“ Lishui Zhejiang University Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer NCT05933889n/a1 site๐Ÿ“ London Royal Marsden NHS Foundation Trust ยท Tests: Molecular Analysis, Radiomic/ Morphological analysis Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) NCT06572423NA1 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Personalized ultrafractionated stereotactic adaptive radiotherapy, Volume Modulated Arc Therapy, Computed Tomography, Pโ€ฆ Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. NCT06059261Phase 21 site๐Ÿ“ Chongqing Chongqing University Cancer Hospital ยท Tests: Envafolimab and recombinant human endostatin combined with chemoradiotherapy Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC NCT06657690Phase 21 site๐Ÿ“ Zhuhai Sun Yat-sen University ยท Tests: Irinotecan liposome, S-1 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial NCT05674396Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Stereotactic body radiotherapy, Traditional Palliation A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma NCT06976190Phase 31 site๐Ÿ“ Guangzhou Lepu Biopharma Co., Ltd. ยท Tests: MRG003 + Pucotenlimab, Gemcitabine, Docetaxel, or Capecitabine MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC NCT07331428Phase 21 site๐Ÿ“ Fuzhou Fujian Cancer Hospital ยท Tests: MRG003, Tislelizumab, Capecitabine Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer NCT06627998n/a1 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: Diagnostic (chest x-ray /DXA)and clinical data collected for clinical practice A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer NCT07455019Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: The treatment group using pembrolizumab combined with anlotinib and radiotherapy and chemotherapy Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma NCT06755567n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: MRI-based radiomics-clinical model Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Routine care as per site standard
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy